Davis Polk advised the joint book-running managers and representatives of the underwriters in the offering. First American Financial Corporation executed the offering of $650 million principal amount...
First American Financial’s $650 Million Senior Notes Offering
Aligos Therapeutics’ $83.6 Million Public Offering
Latham & Watkins LLP represented Aligos Therapeutics, while Davis Polk advised the representatives of the several underwriters in the offering. Aligos Therapeutics, Inc. (Nasdaq: ALGS) announced...
Sprinklr’s $254 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in the IPO. Sprinklr, Inc. completed its $254 million initial public offering of 16,625,000 shares of Class A...
StoneCo’s $500 Million Notes Offering
Davis Polk & Wardwell and Pinheiro Neto advised StoneCo. Simpson Thacher & Bartlett and Pinheiro Guimarães advised J.P. Morgan Securities LLC; Banco Bradesco BBI S.A.; Banco...
Apria’s $139.7 Million Stock Offering
Simpson Thacher represented Apria, while Davis Polk advised the representatives of the several underwriters in the offering. Apria, Inc. announced an $139.7 million SEC-registered offering of 5,175,000...
Clear Channel’s $1.05 Billion Notes Offering
Davis Polk advised the representative of the initial purchasers in the offering. Clear Channel Outdoor Holdings, Inc. executed the offering of $1.05 billion aggregate principal amount of...
NeuroPace’s $102 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in the offering. NeuroPace, Inc. executed its initial public offering of 6,900,000 shares of common stock at...
Recursion Pharmaceuticals’ $500 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in the offering. Recursion Pharmaceuticals, Inc. executed its $500 million initial public offering of 27,878,787 shares of Class...
Maravai LifeSciences’s $646.9 Million Secondary Offering
Davis Polk advised the joint book-running managers in the offering. The $646.9 million secondary offering of 20,700,000 shares of common stock of Maravai LifeSciences Holdings, Inc....
Paya’s $245 Million Common Stock Offering
Davis Polk advised the representatives of the several underwriters in the offering. Paya Holdings Inc. executed the $245 million SEC-registered offering of 20,000,000 shares of common stock,...
Playtika’s $600 Million Notes Offering
Davis Polk advised the representative of the initial purchasers in the offering. Playtika Holding Corp. executed its offering of $600 million aggregate principal amount of its 4.250%...
AmerisourceBergen’s $2 Billion Facilities
Davis Polk advised the joint lead arrangers and the agent in the deal. A $1 billion term loan facility was provided to AmerisourceBergen Corporation to finance...